These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3651513)

  • 1. Differences in the association of the progesterone receptor ligated by antiprogestin RU38486 or progestin ORG 2058 to chromatin components.
    Geier A; Bella R; Beery R; Haimsohn M; Lunenfeld B
    Biochim Biophys Acta; 1987 Oct; 931(1):78-86. PubMed ID: 3651513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the physical properties of the nuclear progesterone receptor, bound to antiprogestin RU 486 or progestin ORG 2058, following limited proteolysis.
    Geier A; Bella R; Beery R; Lunenfeld B
    Steroids; 1990 Jun; 55(6):283-8. PubMed ID: 2385853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the progesterone receptor solubilized by micrococcal nuclease and DNase I digestion.
    Geier A; Yemini-Blauer Z; Lunenfeld B; Nebel L
    J Steroid Biochem; 1986 Aug; 25(2):271-6. PubMed ID: 3747526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical-chemical properties of the estrogen receptor solubilized by micrococcal nuclease.
    Geier A; Haimsohn M; Beery R; Lunenfeld B
    J Steroid Biochem; 1985 Aug; 23(2):137-43. PubMed ID: 4033115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the 4-hydroxytamoxifen (4-OHTAM) bound estrogen receptor of MCF-7 cells solubilized by micrococcal nuclease.
    Geier A; Haimsohn M; Beery R; Lunenfeld B
    J Steroid Biochem; 1985 Nov; 23(5A):547-51. PubMed ID: 4079372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiprogestin-receptor complexes: differences in the interaction of the antiprogestin RU38,486 and the progestin R5020 with the progesterone receptor of human breast cancer cells.
    Mullick A; Katzenellenbogen BS
    Biochem Biophys Res Commun; 1986 Feb; 135(1):90-7. PubMed ID: 3954780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical-chemical properties of the estrogen receptor released by deoxyribonuclease I.
    Geier A; Beery R; Haimsohn M; Kessler E; Lunenfeld B
    J Steroid Biochem; 1986 May; 24(5):971-6. PubMed ID: 3724148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the nuclear estrogen receptor from MCF-7 cells by limited proteolysis.
    Geier A; Beery R; Haimsohn M; Lunenfeld B
    J Steroid Biochem; 1987 Jan; 26(1):35-40. PubMed ID: 3821106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.
    Terakawa N; Shimizu I; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the 4-hydroxytamoxifen (4-OHTAM) bound nuclear estrogen receptor from MCF-7 cells by limited proteolysis.
    Geier A; Beery R; Haimsohn M; Lunenfeld B
    J Steroid Biochem; 1987 Nov; 28(5):471-8. PubMed ID: 3682814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of calf uterine progesterone receptor: analysis of the process when receptor is bound to progesterone and RU38486.
    Moudgil VK; Hurd C
    Biochemistry; 1987 Aug; 26(16):4993-5001. PubMed ID: 3663641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
    Horwitz KB
    Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestin and antiprogestin effects on progesterone receptor transformation.
    Spilman CH; Gibson RE; Beuving DC; Campbell JA
    J Steroid Biochem; 1986 Jan; 24(1):383-9. PubMed ID: 2939296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3H-ZK 98,734, a new 11 beta-aryl substituted antigestagen: binding characteristics to receptor and serum proteins.
    Pollow K; Juchem M; Grill HJ; Manz B; Beier S; Henderson D; Schmidt-Gollwitzer K; Elger W
    Contraception; 1989 Aug; 40(2):213-32. PubMed ID: 2758842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologically distinct binding molecules for progesterone and RU38486 in the chick oviduct cytosol.
    Eliezer N; Hurd CB; Moudgil VK
    Biochim Biophys Acta; 1987 Jun; 929(1):34-9. PubMed ID: 3593772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RU486 is not an antiprogestin in the hamster.
    Gray GO; Leavitt WW
    J Steroid Biochem; 1987 Nov; 28(5):493-7. PubMed ID: 3682817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form.
    el-Ashry D; Oñate SA; Nordeen SK; Edwards DP
    Mol Endocrinol; 1989 Oct; 3(10):1545-58. PubMed ID: 2608048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of female sexual behavior with intracerebral implants of antiprogestin RU 38486: correlation with binding to neural progestin receptors.
    Etgen AM; Barfield RJ
    Endocrinology; 1986 Oct; 119(4):1610-7. PubMed ID: 3757904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in pattern of release of triiodothyronine (T3) and tetraiodothyronine (T4) associated receptors from chromatin by micrococcal nuclease.
    Yiannakouris N; Valcana T
    Horm Metab Res; 1998 Jan; 30(1):7-11. PubMed ID: 9503032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Binding characteristics of RU 486 with glucocorticoid and progestin receptors].
    Fukuoka H; Jimbo T
    Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):698-706. PubMed ID: 3224726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.